We previously reported that antiestrogen-liganded estrogen receptor b (ERb) transcriptionally activates the major detoxifying enzyme quinone reductase (QR) (NAD(P)H:-quinone oxidoreductase). Further studies on the functional role of ERb-mediated upregulation of antioxidative enzymes indicated protective effects against estrogeninduced oxidative DNA damage (ODD). We now report on in vivo and in vitro studies that show that ERbmediated upregulation of QR are involved in the protection against estrogen-induced mammary tumorigenesis. Using the August Copenhagen Irish (ACI) model of estrogen-induced carcinogenesis, we observed that increased ODD and decreased QR expression occur early in the process of estrogen-induced mammary tumorigenesis. Prevention of ACI mammary gland tumorigenesis by tamoxifen was accompanied by decreased ODD and increased QR levels. These correlative findings were supported by our findings that downregulation of QR levels led to increased levels of estrogen quinone metabolites and enhanced transformation potential of 17b-estradiol treated MCF10A non-tumorigenic breast epithelial cells. Concurrent expression of ERb and treatment with 4-hydroxytamoxifen decreased tumorigenic potential of these MCF10A cells. We conclude that upregulation of QR, through induction by tamoxifen, can inhibit estrogen-induced ODD and mammary cell tumorigenesis, representing a possible novel mechanism of tamoxifen prevention against breast cancer.
Although it is widely accepted that the risk of developing breast cancer is directly related to one's lifetime exposure to estrogen, the precise role of estrogen in the initiation and progression of breast cancer has yet to be determined. It has been hypothesized that initiation results from induction of DNA damage by estrogen metabolites and in concert with pre-existing lesions, whereas upregulation of mitogenic genes through the estrogen receptor (ER) may facilitate progression (Liehr, 2000) .
In normal and breast cancer cells, estrogens may be oxidized by extrahepatic cytochrome P450 enzymes to hydroxy-catecholestrogens and further oxidized to the semiquinone and quinone form (Jefcoate et al., 2000) . This is potentially harmful given that the quinone can bind to DNA, resulting in DNA adducts. Redox cycling, involving quinone and unstable semiquinone interconversions, causes hydroxyl radical formation that can lead to hydroxylated bases (e.g. 8-hydroxydeoxyguanine, 8-OH-dG) and permanent mutation if not repaired (Liehr, 2000) . Glutathione-S-transferase (GST) detoxifies these quinones by conjugation with glutathione, and catechol O-methyltransferase (COMT) detoxifies the hydroxy-catecholestrogens by methylation (Liehr, 2000) . We provide data in this report that support the involvement of quinone reductase (QR) in the metabolism of catechol estrogen quinones.
We previously determined that QR is upregulated by tamoxifen-liganded ERb in breast epithelial cell lines (Montano et al., 1998) . Our initial studies on the functional role of ERb-mediated regulation of QR indicate protective effects against estrogen-induced oxidative DNA damage (ODD) (Bianco et al., 2003) . For the present studies our immediate goal was to determine whether estrogen-induced ODD could be observed in in vivo and in vitro models of estrogeninduced mammary tumorigenesis and if tamoxifenliganded ERb can inhibit this process. Further characterization of the downstream consequences of ER regulation of antioxidative enzymes on cell phenotype should provide important insights into protein activity or pathways that are disrupted and allow for enhanced tumorigenic effects of estrogens.
Chronic treatment with E 2 induces mammary cancer in 100% of ovary-intact ACI rats, with a median latency of 20 weeks (Harvell et al., 2000; Li et al., 2002a, b) . Estrogen-induced mammary cancer is also accompanied by genomic instability in the form of loss of heterozygosity (Harvell et al., 2000; Li et al., 2002a) . TAM has been shown to prevent ACI rat mammary gland tumor formation, and this effect appears to be mediated by the ER (Li et al., 2002b) .
To examine 8-OH-dG and QR levels, we used quantitative immunohistochemistry, a previously established method for quantifying 8-OH-dG levels in cells (Nunomura et al., 2001) . In vitro methods to determine oxidative damage to DNA such as high-performance liquid chromatography with electrochemical detection (HPLC-EC) have produced controversial results (Helbock et al., 1999) , perhaps owing to prior isolation of DNA that may create artificial oxidative modification. This method also allowed us to quantify 8-OH-dG and QR immunoreactivity per cell rather than total 8-OH-dG and QR in a cell population. This is important because of the proliferative effects of E 2 on breast epithelial cells, and the use of in vitro methods would have made it difficult to distinguish between E 2 regulation of ODD or QR vs E 2 -induced increase in cell number. We also wanted to focus on the effects of E 2 on luminal epithelial cells wherein breast cancers are thought to originate. Finally, ERb is mainly expressed in the nuclei of epithelial cells.
We examined two time points (4 and 7 months) after E 2 -treatment for increases in 8-OH-dG. The choice of time points is based on when genomic instability (4 months) and mammary tumors (6 months) were first reported in these animals (Harvell et al., 2000; Li et al., 2002a, b) . We observed increased ODD in the mammary gland of ACI rats after chronic E 2 treatment ( Figure 1a ). This increase in ODD was evident in rats treated with E 2 for 4 months, before the period when mammary tumors were observed after E 2 treatment. A decrease in ODD to below basal levels was evident in TAM-treated rats, and TAM co-treatment led to a significant decrease in ODD in E 2 -treated mice (Po0.01; Figure 1a ).
We then determined whether we can correlate changes in ODD levels with QR levels. E 2 induced a 440% decrease in QR levels after 4 and 7 months of treatments ( Figure 1b ). Although we have not observed E 2 -induced decrease in QR levels in breast epithelial cell lines (Montano et al., 1998) , Ansell et al. (2004) reported decreased QR expression in the uteri of E 2 -treated mice. Co-treatment with TAM led to an increase in QR levels in E 2 -treated animals, to levels similar to that observed in control (untreated) animals ( Figure 1b) . A significant increase in QR levels was observed in animals treated with TAM alone compared to control animals. As our previous studies indicate that ERb mediates 4-hydroxytamoxifen (TOT) protective effects (Bianco et al., 2003) , we performed immunohistochemistry to confirm ERb expression in ACI rat mammary glands (Figure 1c) .
Although important physiological and correlative information can be obtained from ACI studies, ERa is expressed in ACI rat mammary gland (Saji et al., 2000) and we cannot eliminate the possibility that estrogeninduced ODD and mammary tumor formation is due to ERa-mediated transcriptional regulation. To more directly assess the role of QR and antiestrogen-liganded ER in the protection against mammary epithelial cell tumorigenesis, we manipulated the levels of QR and ER in MCF10A cells. As we did not observe expression of full-length ERa and ERb in MCF10A cells (Bianco et al., 2003) , infecting MCF10 cells with ERb retroviruses will allow us to determine the sufficiency for ERb in the protection against E 2 -induced ODD and transformation.
There have been conflicting reports of cytochrome P450 expression in MCF10A cells (Guo et al., 2001; Thomas et al., 2006 ). Thus, we tested if treatment with physiological concentrations of E 2 and downregulation of QR can lead to an increase in the levels of reactive estrogen metabolites. Catechol estrogen quinones cannot be directly analysed because of their instability. In addition to forming specific depurinating adducts, these electrophilic metabolites react with glutathione (GSH) to form conjugates (Jefcoate et al., 2000) . In breast cells, GSH moieties are hydrolysed to cysteine (Cys) and then acetylated to NAcCys. Thus, total estrogen quinone metabolites is the total of GSH-, 
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E 2 E 2 E 2 TAM (4 mos) +TAM (7 mos) (7 mos) (7 mos) Figure 1 8-OH-dG levels and QR levels in ACI rats. Female ACI rats were either (1) untreated (Control), (2) received a single 20 mg cholesterol pellet containing 3 mg of E 2 (3) received a single 40-mg pellet of tamoxifen citrate (TAM), or (4) received a 40-mg pellet of TAM, and a week later, a 20 mg cholesterol pellet containing 3 mg of E 2 . Mammary glands from 4-8 animals/group were analysed for (a) 8-OH-dG and (b) QR levels as described in the 'Supplementary material'. *Denotes Po0.05 vs control as determined by Analysis of Variance (ANOVA); a Denotes Po0.05 vs control as determined by ANOVA; b Denotes Po0.05 vs E 2 -treated rats as determined by ANOVA. (c) Sections from mammary glands of untreated rats were stained for ERb as described in the 'Supplementary material'.
Cys-, and NAcCy-conjugated metabolites (Rogan et al., 2003) . We observed higher levels of estrogen quinone conjugates in MCF10A cells infected with QR siRNA retroviruses when compared to cells infected with control retroviruses (Table 1) . Thus, the enzymatic machinery for generating estrogen quinone metabolites is functional in MCF10A cells, and QR is involved in the metabolism of estrogen quinones.
To examine long-term effects of downregulation of QR and concurrent E 2 exposure, we examined the transformation potential of non-tumorigenic MCF10A cells. We downregulated QR expression using QR siRNA retroviruses (Figure 2b ). E 2 did not induce significant colony formation of MCF10A cells plated on soft agar (Figure 2a) . We observed enhanced colony formation upon downregulation of QR using QR siRNA retroviruses, but a more drastic increase in colony formation was observed after treatment of QR siRNA-infected cells with E 2 (Figure 2a) . The transforming potential of E 2 -treated/QR siRNA-infected cells was comparable to cells transfected with Ha-RAS expression vector. Ha-RAS-infected MCF10A cells give rise to persistent lesions with potential for preneoplastic progression or sporadically progress to carcinomas in immunodeficient mice (Dawson et al., 1996) . Co-transfection with ERb expression vector and treatment with TOT compensated for the silencing effects of QR siRNA by inducing QR transcription and inhibiting E 2 -transformation in MCF10A cells (Figure 2a) . We focused on the protective effects of ERb because we see inhibition of E 2 -induced ODD only with ERb, but not with ERa (Figure 1,  Supplementary material) .
We observed relatively modest induction of QR levels by TAM in the ACI rat mammary gland. This level of increase is comparable to that observed in the rat prostate in the presence of potent inducers of QR in vitro (sulforaphane, b-naphthoflavone, curcumin, dimethyl fumarate) (Jones and Brooks, 2006) . Modest induction of phase 2 enzymes (QR and total GST) have been also been observed in the liver tissues of F344 rats treated with sulforaphane and sulforaphane nitrile derived from cruciferous vegetables (Matusheski and Jeffery, 2001 ). Cruciferous vegetables decrease the incidence preneoplastic lesions in the colon and liver when fed simultaneously with a carcinogen to F344 rats (Kassie et al., 2003) . Therefore, even relatively modest inductions of phase 2 enzymatic activity can be sufficient to protect against carcinogenesis. Moreover, the ER regulates the expression of other antioxidative enzymes, such as GST-Pi and g-glutamylcysteine synthetase heavy subunit (Montano et al., 2004) in addition to QR, suggesting that ER may play a broad role in protection against antioxidative stress. Finally, breast cancer develops over decades, raising the possibility that chronic, low-level phase 2 enzyme induction might be sufficient to prevent the disease.
Together, our results provide supporting evidence that upregulation of antioxidative enzymes, through induction by TOT-liganded ERb, can prevent estrogeninduced mammary cells tumorigenesis. Together our studies have important implications for therapies targeted at ER-mediated transcription, and also for therapeutic protocols addressing direct mutagenic effects of estrogens.
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